website statistics
German Biotech Database
Biotechgate Biotechgate Global Database › Global Trial › Global Log-in ›
Life Sciences Database
Database Life Science Map Statistics News & Events About us

News in the Life Sciences Industry

Results 81 - 100 out of 412 displayed.
«  1  2  3  4 5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21 »

InferVision AI Assists the European Commission Monitoring COVID-19 Variants

Read more ››
By: PR Newswire Association LLC. - 16 Aug 2021

Lebrikizumab significantly improved skin clearance and itch in people with moderate-to-severe atopic deramatitis in two Phase 3 trials

Read more ››
By: PR Newswire Association LLC. - 16 Aug 2021
Related companies:  Almirall Hermal GmbH

Sino Biological Announces Successful Closing of 4.98 Billion RMB Public Offering and Listing on the Shenzhen ChiNext Stock Exchange

Read more ››
By: PR Newswire Association LLC. - 16 Aug 2021

Rentschler Biopharma breaks ground at new U.S. production site in greater Boston

Read more ››
By: GlobenewsWire - 12 Aug 2021
Related companies:  Rentschler Biopharma SE | Rentschler Biopharma Inc. | Rentschler Biopharma Inc.

atai Launches Revixia Life Sciences to Develop Salvinorin A for a Variety of Mental Health Conditions

Read more ››
By: GlobenewsWire - 12 Aug 2021
Related companies:  ATAI Life Sciences AG

NUHS Embarks on Holomedicine Research in Singapore, Using Mixed Reality Technology to Enhance Diagnosis, Education and Patient Care

Read more ››
By: PR Newswire Association LLC. - 12 Aug 2021

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons on 10 August 2021

Read more ››
By: GlobenewsWire - 11 Aug 2021

Immatics Announces Second Quarter 2021 Financial Results and Provides Business Update

Read more ››
By: GlobenewsWire - 10 Aug 2021
Related companies:  Immatics Biotechnologies GmbH

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons on 9 August 2021

Read more ››
By: GlobenewsWire - 10 Aug 2021

InflaRx Announces Positive Data from Second Interim Analysis of Ongoing Phase IIa Open Label Study with Vilobelimab in Pyoderma Gangraenosum

Read more ››
By: GlobenewsWire - 10 Aug 2021
Related companies:  InflaRx N.V.

VERAXA Biotech and Indivumed Cooperate on the Development of Precision Oncology Antibody Drugs

Read more ››
By: PR Newswire Association LLC. - 10 Aug 2021
Related companies:  Indivumed GmbH

First patient enrolled in a Phase III study with QUTENZA® in post-surgical neuropathic pain

- The study AV001 aims to include the treatment of post-surgical neuropathic pain (PSNP) in the U.S. label;- QUTENZA® is currently approved for use in adults in the treatment of neuropathic pain associated with postherpetic neuralgia and for the treatment of neuropathic pain associated with diabetic... Read more ››
By: PR Newswire Association LLC. - 10 Aug 2021
Related companies:  Grünenthal Group

atai Life Sciences to Host Conference Call and Webcast to Discuss Second Quarter 2021 Financial Results and Provide Business Update

Read more ››
By: GlobenewsWire - 10 Aug 2021
Related companies:  ATAI Life Sciences AG

BioNTech Announces Second Quarter 2021 Financial Results and Corporate Update

Read more ››
By: GlobenewsWire - 09 Aug 2021
Related companies:  BioNTech SE

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons on 5 August 2021

Read more ››
By: GlobenewsWire - 09 Aug 2021

atai Life Sciences to Present at the 41st Annual Canaccord Genuity Growth Conference

Read more ››
By: GlobenewsWire - 07 Aug 2021
Related companies:  ATAI Life Sciences AG

InflaRx to Present at the BTIG Virtual Biotechnology Conference

Read more ››
By: GlobenewsWire - 06 Aug 2021
Related companies:  InflaRx N.V.

SPR Therapeutics CEO Maria Bennett Selected as Winner of EY Entrepreneur of the Year in East Central Region

Read more ››
By: GlobenewsWire - 06 Aug 2021
Related companies:  Bruker Daltonics SPR Zweigniederlassung der Bruker Daltonik GmbH | SPR Therapeutics, Inc.

FDA approves Nexviazyme® (avalglucosidase alfa-ngpt), an important new treatment option for late-onset Pompe disease

Read more ››
By: GlobenewsWire - 06 Aug 2021

InflaRx Reports Second Quarter 2021 Financial & Operating Results

Read more ››
By: GlobenewsWire - 05 Aug 2021
Related companies:  InflaRx N.V.
«  1  2  3  4 5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21 »

Looking for companies outside of Germany?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

  • September 2021
    • Navarro: BioSpain 2021
  • October 2021
    • HealthTech Innovation Days
    • 8th Annual HealthTech Investment Forum
See Events »
Add an Event »

Latest company news

Novo Nordisk A/S – Share repurchase programme
27 Sep 2021 (GlobenewsWire)

Sartorius to expand Business Operations in North America
27 Sep 2021 (PR Newswire Association LLC.)

Sanofi: Availability of the Q3 2021 Memorandum for modelling purposes
24 Sep 2021 (GlobenewsWire)

Biotechgate database

About Biotechgate
The German Biotech Database is a product of Venture Valuation and part of the global Life Sciences lead generation and intelligence platform Biotechgate. Our mission is to provide up-to-date company and business information of the Biotech, Pharma and Medtech sectors to professionals everywhere, in order to support them in identifying the most appropriate business partners, customers and suppliers.

Visit our global portal: www.biotechgate.com